Neutrophil gelatinase-associated lipocalin: a biochemical marker for acute kidney injury and long-term outcomes in patients presenting to the emergency department

Kah-Hui-Brian TEO; Swee-Han LIM; Ying HAO; Yin-Keong-Daryl LO; Ziwei LIN; Manish KAUSHIK; Chieh-Suai TAN; Mohammed-Zuhary THAJUDEEN; Choon-Peng JEREMY-WEE.
Singapore medical journal ; : 479-486, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1007327

Documentos relacionados

  1. Neutrophil gelatinase-associated lipocalin: a biochemical marker for acute kidney injury and long-term outcomes in patients presenting to the emergency department.
  2. Role Portrayed by Serum NGAL and Vitamin D in Patients with Bone Tumors.
  3. Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss.
  4. [Frequency of occurrence and risk factors for acute kidney injury after radical cystectomy].
  5. Serial Measurements of Neutrophil Gelatinase-Associated Lipocalin levels for Assessment of Contrast Induced Nephropathy among Chronic Kidney Disease Patients Who Underwent Elective Coronary Angiography.
  6. Effects of 20% albumin infusion therapy during liver transplantation on plasma neutrophil gelatinase-associated lipocalin level: A randomized controlled trial.
  7. Contrast induced nephropathy after coronary or vascular intervention: More biomarkers than answers.
  8. Validation of Cardiac Surgery-Associated Neutrophil Gelatinase-Associated Lipocalin Score for Prediction of Cardiac Surgery-Associated Acute Kidney Injury.
  9. Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury.
  10. The Importance of Neutrophil Gelatinase - Associated Lipocalin and Liver Type Fatty Acid Binding Protein in Acute Kidney Injury.